Compare ARK Genomic Revolution ETF (ARKG) vs Invesco NASDAQ 100 ETF (QQQM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Invesco NASDAQ 100 ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Invesco NASDAQ 100 ETF trades at $295.63. Which is the better fit depends on your goals.
| ARKG | QQQM | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $307.23 |
52-Week Low | $23.09 | $228.02 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
QQQM trades at $298.71, up 0.32% with a bullish technical signal from moving averages. The ETF benefits from Nasdaq 100 exposure, particularly growth-oriented tech stocks, with recent news highlighting SpaceX's inclusion in the index. Support levels are firm at $295 and $293, while resistance sits near $299 and $301.
The outlook remains positive given the ETF's focus on AI-driven growth companies and strong institutional interest. Risks include market volatility and concentration in tech, but long-term growth prospects from sectors like AI infrastructure support a favorable view for growth-oriented investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Invesco NASDAQ 100 ETF
QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.
Read more on QQQM →
